AGP Picks
View all

United Kingdom Globe Dispatch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on United Kingdom Globe Dispatch.

Press releases published on September 8, 2026

XS.com Brings Traders and Partners Together at Private Seminar in Lima, Peru
RIFT PRESENTS A SYSTEM TO REDESIGN ARCHITECTURE OF OPPORTUNITY AS AI TRANSFORMS WORK
National Center for Falcons Unveils International Saudi Falcons and Hunting Exhibition 2026
Five Reputable 250mL Large-Volume Magnetic Rack Manufacturers in China 2026: Driving Biotech Separation Efficiency
Organised Fraud Rings Use Deepfakes and Reused Identities to Target Digital Businesses, Shufti Identity Fraud Report 2026 Finds
World Physiotherapy Day 2026: Early Neurorehabilitation | Dr. Rao's Hospital
Top PCB Assembly Manufacturer Strengthens Electronics Manufacturing Capabilities
62% of communicators say meaningful engagement includes employee action, but only 8% connect the data
Gen Z turns to AI for more than inspiration as trust in holiday planning grows, finds Vision One Research
SHIRO & Co. Publishes Updated 'The Supervisory Layer' Observation With Formal HOLD State
MoneySimpler Launches Retirement Income System, AI Trading Offers U.S. Retiree $7,700 Potential Daily Income
New case study: Newcastle City Council and Purple set the blueprint for connected cities with OpenRoaming
Industrial Valve Training Programme Expanded with Interactive 3D Models, Video Lessons, and Component‑Level Walkthroughs
Composition Notebook Market Industry Outlook Strengthens Amid Rising Global Demand
Compressor Case Diver Market Value Expected To Grow At 6.9% CAGR, Reaching  $1.93 Billion By 2030
Dr. Gillian Cannon Joins Lindus Therapeutics’ Board as a Non-Executive Director
Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
Transaction in Own Shares
4BIO Capital leads oversubscribed $33 Million Seed Financing of Cloverleaf Bio, Advancing Novel RNA-Based Cancer Therapeutics
Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

United Kingdom Globe Dispatch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.